Index 265
nucleic acids 195
circulating 194–195, 250
occult animals 47
occult periods 45
occupational risks 34–35
Oceania 5, 6
annual incidence 6, 9
eradication programmes 8
molecular typing 65
Old World camelids, Mycobacterium bovis in 84
One Health 13, 31–32, 36–37, 38, 238, 242,
248–250
Organisation for Economic Co-operation and
Development (OECD) 3
overpopulation 31
Pakistan, water buffalo 84
Palestine, raw milk 20
Paraguay, Mycobacterium bovis 65
parasitic worms 162
parsimonious models 45
pasteurisation 17, 19, 20, 22, 33, 35, 36, 226, 239,
240, 242–243
pasture 83, 122
badgers 99
Mycobacterium bovis on 47
pathogen genomics revolution 59
pathogen genotype–phenotype associations 67
pathogen genotyping 70
pathogen-associated molecular patterns
(PAMPs) 140, 143
pathogenesis 61, 115
pathogenic mycobacteria 126–127
PE/PPE genes 112–113
peptides 176, 178, 179, 196, 198, 250, 251
biomarkers 196
peptidomes 196
peripheral blood mononuclear cells (PBMCs) 115,
174, 180, 197
perturbation effect 100
pets 22
phagocytic cells 197
phenolic glycolipids (PGL) 111
PhoPR 113–114
phthiocerol dimycocerosate (PDIM) 110–111
phylodynamics 69
pigs 65, 84, 134, 158, 249
black 83
domestic 82–84
economic losses 82
feral 83–84, 95, 98
husbandry 82
lesions 82, 83
lymph nodes 83
Mycobacterium avium complex (MAC) in 82
Mycobacterium bovis in 95–96
Mycobacterium caprae in 84
New Zealand 83, 95, 232
Spain 83
USA 84
pleurisy 130, 131
pleuropneumonia 2
pneumonia 182
policy 228, 230, 249, 253
politicians 229, 230, 236, 240, 242
polyfunctional T cells 155–156
polyketide synthases (PKS) 110
polymerase chain reaction 127
populations, rural 238, 240
possums 32, 83, 84, 99, 134, 192, 206
BCG 213, 218
culling 213
lesions 94
lymph nodes 94
Mycobacterium bovis in 93–94, 97, 99
New Zealand 93–94, 98, 234, 236
vaccination 213–214
see also brushtail possums
post-mortems 46, 47, 124
wildlife 232
poultry 158
poverty 33, 238, 253
predators 98
prevention 18
primates 196
non-human 129, 155
pro-apoptotic proteins 145
production animals 80
production risks 227
programmes
benefit-cost analysis 228–229, 236, 253
communication 230, 237
compulsory 227
costs 228
development 227
eradication 8, 9, 13, 14, 81, 82
funding 227, 229, 230, 237
high GNI countries 225–231
implementation 227, 230–231, 237–238
legal status 227, 235
planning 228, 236
policies 229–230, 237
purpose 226, 235
stakeholder support 227–228, 235–236
strategic objectives 226–227, 230, 235
voluntary 227
see also control, programmes
protected species 100
protection
correlates 210–211
markers 252